Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bantel

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cell Death and Differentiation|March 26, 2003
Apoptosis in hepatitis C virus infectionH Bantel, K Schulze-Osthoff
Deutsche Medizinische Wochenschrift (1946)|December 22, 1999
[Initial manifestation of primary intestinal lymphangiectasis as acute abdomen]H Bantel, M Gregor, R Lamberts
Cell Death and Differentiation|August 5, 2000
In situ monitoring of caspase activation in hepatobiliary diseasesH Bantel, P Ruck, K Schulze-Osthoff
Gastroenterology|February 24, 2001
Molecular mechanisms of glucocorticoid resistanceH Bantel, W Domschke, K Schulze-Osthoff
European Cytokine Network|January 16, 1999
Activation of caspases by death receptorsH Bantel, T Brüning, K Schulze-Osthoff
European Journal of Cell Biology|April 27, 2001
Detection of elevated caspase activation and early apoptosis in liver diseasesH Bantel, P Ruck, M Gregor, et al.
Zeitschrift Fur Gastroenterologie|March 14, 2014
[Cytokeratin 18 as marker for non-invasive diagnosis and prognosis of acute and chronic liver diseases]A Canbay, A Feldstein, B Kronenberger, et al.
The American Journal of Gastroenterology|August 5, 2000
Abnormal activation of transcription factor NF-kappaB involved in steroid resistance in chronic inflammatory bowel diseaseH Bantel, W Domschke, K Schulze-Osthoff, et al.
Cell Death & Disease|October 26, 2013
Increased plasma levels of CK-18 as potential cell death biomarker in patients with HELLP syndromeK John, S Wielgosz, K Schulze-Osthoff, et al.
Alimentary Pharmacology & Therapeutics|December 3, 2016
Letter: cytokeratin-18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization. Authors' replyH Bantel, F Wandrer, B Bock, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cell Death and Differentiation|March 26, 2003
Apoptosis in hepatitis C virus infectionH Bantel, K Schulze-Osthoff
Deutsche Medizinische Wochenschrift (1946)|December 22, 1999
[Initial manifestation of primary intestinal lymphangiectasis as acute abdomen]H Bantel, M Gregor, R Lamberts
Cell Death and Differentiation|August 5, 2000
In situ monitoring of caspase activation in hepatobiliary diseasesH Bantel, P Ruck, K Schulze-Osthoff
Gastroenterology|February 24, 2001
Molecular mechanisms of glucocorticoid resistanceH Bantel, W Domschke, K Schulze-Osthoff
European Cytokine Network|January 16, 1999
Activation of caspases by death receptorsH Bantel, T Brüning, K Schulze-Osthoff
European Journal of Cell Biology|April 27, 2001
Detection of elevated caspase activation and early apoptosis in liver diseasesH Bantel, P Ruck, M Gregor, et al.
Zeitschrift Fur Gastroenterologie|March 14, 2014
[Cytokeratin 18 as marker for non-invasive diagnosis and prognosis of acute and chronic liver diseases]A Canbay, A Feldstein, B Kronenberger, et al.
The American Journal of Gastroenterology|August 5, 2000
Abnormal activation of transcription factor NF-kappaB involved in steroid resistance in chronic inflammatory bowel diseaseH Bantel, W Domschke, K Schulze-Osthoff, et al.
Cell Death & Disease|October 26, 2013
Increased plasma levels of CK-18 as potential cell death biomarker in patients with HELLP syndromeK John, S Wielgosz, K Schulze-Osthoff, et al.
Alimentary Pharmacology & Therapeutics|December 3, 2016
Letter: cytokeratin-18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization. Authors' replyH Bantel, F Wandrer, B Bock, et al.
Pageof 3